2cureX AB (publ) (2CUREX.ST)

SEK 0.4

(-5.24%)

Eps Summary of 2cureX AB (publ)

  • 2cureX AB (publ)'s latest annual eps in 2023 was -1.85 SEK , down -12.18% from previous year.
  • 2cureX AB (publ)'s latest quarterly eps in 2024 Q2 was -0.27 SEK , down 0.0% from previous quarter.
  • 2cureX AB (publ) reported an annual eps of -1.56 SEK in 2022, down -35.65% from previous year.
  • 2cureX AB (publ) reported an annual eps of -1.15 SEK in 2021, down -112.96% from previous year.
  • 2cureX AB (publ) reported a quarterly eps of -0.27 SEK for 2024 Q2, down 0.0% from previous quarter.
  • 2cureX AB (publ) reported a quarterly eps of -0.46 SEK for 2023 Q2, down -21.05% from previous quarter.

Annual Eps Chart of 2cureX AB (publ) (2023 - 2015)

Historical Annual Eps of 2cureX AB (publ) (2023 - 2015)

Year Eps Eps Growth
2023 -1.85 SEK -12.18%
2022 -1.56 SEK -35.65%
2021 -1.15 SEK -112.96%
2020 -0.54 SEK 20.59%
2019 -0.68 SEK 2.86%
2018 -0.70 SEK -100.0%
2017 -0.35 SEK -356.32%
2016 -0.08 SEK -35.51%
2015 -0.06 SEK 0.0%

Peer Eps Comparison of 2cureX AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -236.364%
Ziccum AB (publ) -1.54 SEK -20.13%
Modus Therapeutics Holding AB (publ) -1.01 SEK -83.168%
BioArctic AB (publ) 2.60 SEK 171.154%
Sprint Bioscience AB (publ) -0.01 SEK -29265.079%
Mendus AB (publ) -4.40 SEK 57.955%
Genovis AB (publ.) 0.94 SEK 296.809%
Intervacc AB (publ) -1.69 SEK -9.467%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -740.909%
Active Biotech AB (publ) -0.17 SEK -988.235%
Magle Chemoswed Holding AB (publ) 1.13 SEK 263.717%
Bio-Works Technologies AB (publ) -1.57 SEK -17.834%
Aptahem AB (publ) -0.05 SEK -3730.228%
Vicore Pharma Holding AB (publ) -3.22 SEK 42.547%
Kancera AB (publ) -0.80 SEK -131.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 81.407%
Fluicell AB (publ) -0.24 SEK -670.833%
Saniona AB (publ) -1.29 SEK -43.411%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -873.684%
Biovica International AB (publ) -2.14 SEK 13.551%
Spago Nanomedical AB (publ) -0.43 SEK -330.233%
AcouSort AB (publ) -1.29 SEK -43.411%
Xintela AB (publ) -0.13 SEK -1323.077%
Abliva AB (publ) -0.09 SEK -1946.46%
Egetis Therapeutics AB (publ) -1.27 SEK -45.669%
Karolinska Development AB (publ) 0.02 SEK 9350.0%
OncoZenge AB (publ) -1.36 SEK -36.029%
Amniotics AB (publ) -0.01 SEK -16718.182%
CombiGene AB (publ) -1.80 SEK -2.778%
Asarina Pharma AB (publ) -0.57 SEK -224.561%
Calliditas Therapeutics AB (publ) -8.69 SEK 78.711%
Camurus AB (publ) 7.78 SEK 123.779%
Corline Biomedical AB -0.08 SEK -2097.15%
IRLAB Therapeutics AB (publ) -3.43 SEK 46.064%
Isofol Medical AB (publ) -0.23 SEK -704.348%
I-Tech AB 1.70 SEK 208.824%
Hansa Biopharma AB (publ) -15.83 SEK 88.313%
Cyxone AB (publ) -0.22 SEK -740.909%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 6.566%
Biosergen AB -0.60 SEK -208.333%
Cantargia AB (publ) -1.65 SEK -12.121%
NextCell Pharma AB -1.03 SEK -79.612%
Xspray Pharma AB (publ) -6.76 SEK 72.633%
Elicera Therapeutics AB (publ) -0.83 SEK -122.892%
Nanologica AB (publ) -2.05 SEK 9.756%
SynAct Pharma AB -6.64 SEK 72.139%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -611.538%
Stayble Therapeutics AB (publ) -0.92 SEK -101.087%
LIDDS AB (publ) -0.63 SEK -193.651%
Lipum AB (publ) -4.45 SEK 58.427%
BioInvent International AB (publ) -5.02 SEK 63.147%
Alzinova AB (publ) -0.41 SEK -351.22%
Oncopeptides AB (publ) -1.96 SEK 5.612%
Pila Pharma AB (publ) -0.47 SEK -293.617%
Guard Therapeutics International AB (publ) -11.26 SEK 83.57%
Scandinavian ChemoTech AB (publ) -1.13 SEK -63.717%
Simris Alg AB (publ) -0.16 SEK -1056.25%
Diamyd Medical AB (publ) -1.60 SEK -15.625%
Xbrane Biopharma AB (publ) -1.27 SEK -45.669%
Ascelia Pharma AB (publ) -3.24 SEK 42.901%
Diagonal Bio AB (publ) -0.32 SEK -478.125%